19th Jun 2019 13:39
(Alliance News) - Allergy Therapeutics PLC on Wednesday said it has appointed Mary Tavener as a non-executive director with immediate effect.
The biotechnology company said Tavener has extensive experience in the healthcare sector, having spent more than 19 years as chief financial officer and board member of Advanced Medical Solutions. She retired as finance boss of Advance Medical at the end of 2018.
Tavener will succeed Stephen Smith as chair of the company's audit committee after the release of the company's for the year ended June 30 in September.
Shares in Allergy Therapeutics were down 1.7% lower at 14.01 pence each on Wednesday afternoon.
Related Shares:
Allergy Thera.